Sort
8,912 grants matching “sars cov 2”
Regulation of antibody-mediated effector functions
$297,692Taia Wang · Stanford University · U19 · FY2025 · AI
SARS-CoV2 Immunity and Cell Biology
$297,649Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research
$297,464Taryn Natalie Young · Stellenbosch University · D43 · FY2024 · TW
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$297,402Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2023 · TW
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$297,388Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2024 · TW
EAGER: Integrating Genotype, Phenotype, and Environment to Identify Biomarkers of Coronavirus Disease Severity and Transmission
$297,382James Weger · Virginia Polytechnic Institute And State University · · FY2020 · BIO
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$297,374Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2025 · TW
Research Core 1: Molecular Measures Core (RC1)
$297,334Virginia B. Kraus · Duke University · P30 · FY2022 · AG
COVID-19 Instrumentation in the RTB
$297,252James Cherry · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19
$297,204Wei Weng · Ingenious Targeting Laboratory, Inc. · R43 · FY2021 · AI
Large scale in vitro production of capped polyadenylated mRNA-based vaccines in solid phase using immobilized enzymes
$297,193Maria Kireeva · Affinity Molecules, Llc · R43 · FY2021 · TR
TRANSMIT: Training Research Acumen iN Students Modeling Infectious Threats
$297,120Lindsay T. Keegan · University Of Utah · U01 · FY2022 · CK
Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU)
$297,077W. Henry Henry Boom · Case Western Reserve University · D43 · FY2024 · TW
Core-- Animal Models
$297,062University Of North Carolina Chapel Hill · P01 · FY2005 · AI
Nanobody toolkit for human coronavirus classification
$297,000Andrew Hayhurst · Texas Biomedical Research Institute · R21 · FY2021 · AI
Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research
$296,960Taryn Natalie Young · Stellenbosch University · D43 · FY2025 · TW
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$296,935Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2022 · TW
New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists
$296,931Barry A Berkowitz · Bessor Pharma, Llc · R43 · FY2024 · AI
Animal/Virology Core
$296,888Stanley Perlman · University Of Iowa · P01 · FY2017 · AI
Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU)
$296,809W. Henry Henry Boom · Case Western Reserve University · D43 · FY2023 · TW
Animal/Virology Core
$296,783Stanley Perlman · University Of Iowa · P01 · FY2021 · AI
Animal/Virology Core
$296,783Stanley Perlman · University Of Iowa · P01 · FY2020 · AI
Animal/Virology Core
$296,782Stanley Perlman · University Of Iowa · P01 · FY2019 · AI
An L-Aptamer-Displacement Assay for High-Throughput Screening of RNA-Targeted Small Molecule Antivirals
$296,650Jonathan Thomas Sczepanski · Texas A&M University · R21 · FY2024 · AI
Targeting galectin-3 to intervene COVID-19
$296,637Hafiz Ahmed · Glycomantra, Inc. · R43 · FY2023 · AI